Behavioral Medicine in Cholangiocarcinoma: Bridging the Gap Between Biology and Behavior
Cancer Control · 2026-05 · 33
DOI: 10.1177/10732748261451653 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Control, online erschienen am 13.05.2026. Verfasst von Leshui Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Behavioral Medicine. Die Arbeit nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science and Technology Major Project for Noncommunicable Chronic Diseases, Natural Science Foundation of Shanghai Municipality, Shanghai White Magnolia Talent Program.
Abstract (Originalsprache)
Cholangiocarcinoma (CCA) is an aggressive malignant tumor with extremely poor prognosis, and its global incidence is increasing, posing a growing public health burden. Behavioral factors, such as diet, alcohol consumption, smoking, physical activity, and psychological status, are closely associated with the development of CCA. This narrative review delves into the multidimensional burden of CCA, including psychological distress, symptom profiles, and socioeconomic impacts. It also summarizes evidence from related gastrointestinal cancers to explain the biological mechanisms through which lifestyle modifications may improve prognosis, including immunomodulation, inflammatory cascades, and metabolic reprogramming. Furthermore, we propose an integrated framework for behavioral medicine and hepatobiliary care, emphasizing the pivotal role of behavioral interventions in enhancing CCA prevention and clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
- School of Clinical Medicine, Qilu Medical University, Shandong, China.
- Department of Medical Services, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
- Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
ORCID-Profile: Susu Luo
Förderung
- National Science and Technology Major Project for Noncommunicable Chronic Diseases
- Natural Science Foundation of Shanghai Municipality
- Shanghai White Magnolia Talent Program
Zitieren
APA
Wang, L., Lu, Y., Qian, Y., Wang, X., Xu, Y., Guo, X., Dong, W., Liu, H., & Luo, S. (2026). Behavioral Medicine in Cholangiocarcinoma: Bridging the Gap Between Biology and Behavior. Cancer Control, 33. https://doi.org/10.1177/10732748261451653
Vancouver
Wang L, Lu Y, Qian Y, Wang X, Xu Y, Guo X, et al. Behavioral Medicine in Cholangiocarcinoma: Bridging the Gap Between Biology and Behavior. Cancer Control. 2026;33. doi:10.1177/10732748261451653
BibTeX
@article{Wang2026,
author = {Wang, Leshui and Lu, Yan and Qian, Ye and Wang, Xiao and Xu, Yihuan and Guo, Xinggang and Dong, Wei and Liu, Hui and Luo, Susu},
title = {Behavioral Medicine in Cholangiocarcinoma: Bridging the Gap Between Biology and Behavior},
journal = {Cancer Control},
year = {2026},
volume = {33},
doi = {10.1177/10732748261451653}
}
EUVIMED